Brandon Isamu Morinaka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Brandon Isamu Morinaka has a total of 183 co-authors. Here are the top co-authors by number of shared publications:
- Tadeusz F. Molinski
University of California, San Diego
14 shared publications - Jörn Piel
Institute of Microbiology, Eidgenössische Technische Hochschule (ETH) Zurich, Vladimir-Prelog-Weg 4, 8093 Zurich, Switzerland
13 shared publications - Muriel Gugger
Institut Pasteur, Université Paris Cité, Collection of Cyanobacteria
7 shared publications - Anna Lisa Vagstad
Institute of Microbiology, Eidgenössische Technische Hochschule (ETH) Zurich, Vladimir-Prelog-Weg 4, 8093 Zurich, Switzerland
6 shared publications - Chin-Soon Phan
Latvian Institute of Organic Synthesis, Aizkraukles street 21, LV-1006 Riga, Latvia
5 shared publications Yi Wei Tooh
Department of Pharmacy, National University of Singapore, Singapore, Singapore
5 shared publications
Latest Publications
- 3 September 2026
- Published by American Chemical Society (ACS) in ACS Catalysis
- Vol. 16 (18) , 17607-17613
Rational Engineering of the Radical SAM Enzyme HtkB Expands the Chemical Space of Cyclophane RiPPs
Cyclophane-containing peptides represent a structurally diverse class of macrocycles with important applications in drug development due to their stability and target specificity. Radical S-adenosylmethionine (rSAM) enzymes are key catalysts for cyclophane formation and execute chemically challenging C(sp2)–C(sp3) crosslinks. However, rSAM cyclophane synthases have generally been restricted to acting on their native or engineered substrates. Here, we report structure-guided engineering of an rSAM cyclophane synthase through mutation of a conserved D214 residue in the rSAM enzyme HtkB. This single amino acid substitution substantially broadens substrate tolerance, enabling macrocyclization of diverse side chains, including polar, aliphatic, and acidic residues. Characterization of the His-to-Leu crosslinked product shows that C–C bond formation is analogous to the wild-type His-to-Lys crosslink and that the regiospecificity and stereospecificity of the enzyme are conserved. These findings reveal the unexpected plasticity of an rSAM cyclophane synthase and open opportunities to engineer rSAM enzymes for broader biocatalytic and therapeutic applications.
- 3 September 2026
- Published by American Chemical Society (ACS) in ACS Catalysis
- Vol. 16 (18) , 17607-17613
Rational Engineering of the Radical SAM Enzyme HtkB Expands the Chemical Space of Cyclophane RiPPs
Cyclophane-containing peptides represent a structurally diverse class of macrocycles with important applications in drug development due to their stability and target specificity. Radical S-adenosylmethionine (rSAM) enzymes are key catalysts for cyclophane formation and execute chemically challenging C(sp2)–C(sp3) crosslinks. However, rSAM cyclophane synthases have generally been restricted to acting on their native or engineered substrates. Here, we report structure-guided engineering of an rSAM cyclophane synthase through mutation of a conserved D214 residue in the rSAM enzyme HtkB. This single amino acid substitution substantially broadens substrate tolerance, enabling macrocyclization of diverse side chains, including polar, aliphatic, and acidic residues. Characterization of the His-to-Leu crosslinked product shows that C–C bond formation is analogous to the wild-type His-to-Lys crosslink and that the regiospecificity and stereospecificity of the enzyme are conserved. These findings reveal the unexpected plasticity of an rSAM cyclophane synthase and open opportunities to engineer rSAM enzymes for broader biocatalytic and therapeutic applications.
- Open Access
- 16 February 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 55 (5) , 2909-2958
Radical enzymatic peptide cyclization in natural product biosynthesis
Cyclic peptides are privileged scaffolds in natural product biosynthesis and drug discovery, valued for their structural diversity, metabolic stability, and potent biological activities. Radical-mediated enzymatic cyclization has emerged as a powerful biosynthetic strategy for constructing structurally complex and bioactive peptide natural products. This review surveys the growing repertoire of radical enzymes, including radical S-adenosylmethionine (rSAM) enzymes, cytochrome P450s, BURP-domain oxidases, and additional enzyme families that catalyze site-selective C–C, C–S, C–N, and C–O bond formation during peptide macrocyclization. Emphasis is placed on radical-driven cyclization reactions involved in natural product biosynthesis, covering both RiPPs and NRPS pathways. Examples of cyclic peptide natural products include vancomycin, arylomicin, telocidin, streptide, and nosiheptide illustrate the mechanistic and structural diversity of radical peptide cyclases. Key emerging themes include a diverse array of side-chain crosslinking, 3–4 residue macrocycles, and unique forms of chirality. This review also discusses advances in genome mining and mechanistic enzymology that continue to reveal new radical transformations and unusual enzyme mechanisms. Collectively, these insights highlight the role of radical enzymology in expanding the structural space of peptide-based natural products and its potential for applications in synthetic biology, drug discovery, and peptide engineering.
- 16 February 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 55 (5) , 2909-2958
Open AccessRadical enzymatic peptide cyclization in natural product biosynthesis
Cyclic peptides are privileged scaffolds in natural product biosynthesis and drug discovery, valued for their structural diversity, metabolic stability, and potent biological activities. Radical-mediated enzymatic cyclization has emerged as a powerful biosynthetic strategy for constructing structurally complex and bioactive peptide natural products. This review surveys the growing repertoire of radical enzymes, including radical S-adenosylmethionine (rSAM) enzymes, cytochrome P450s, BURP-domain oxidases, and additional enzyme families that catalyze site-selective C–C, C–S, C–N, and C–O bond formation during peptide macrocyclization. Emphasis is placed on radical-driven cyclization reactions involved in natural product biosynthesis, covering both RiPPs and NRPS pathways. Examples of cyclic peptide natural products include vancomycin, arylomicin, telocidin, streptide, and nosiheptide illustrate the mechanistic and structural diversity of radical peptide cyclases. Key emerging themes include a diverse array of side-chain crosslinking, 3–4 residue macrocycles, and unique forms of chirality. This review also discusses advances in genome mining and mechanistic enzymology that continue to reveal new radical transformations and unusual enzyme mechanisms. Collectively, these insights highlight the role of radical enzymology in expanding the structural space of peptide-based natural products and its potential for applications in synthetic biology, drug discovery, and peptide engineering.
- 28 May 2025
- Published by Elsevier
- Vol. 717, 119-140
Genome mining and in vivo characterization of triceptides
- 28 May 2025
- Published by Elsevier
- Vol. 717, 119-140
Genome mining and in vivo characterization of triceptides
- 12 May 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (20) , 16850-16863
Peptide Recognition and Mechanism of the Radical S-Adenosyl-l-methionine Multiple Cyclophane Synthase ChlB
Ribosomally synthesized and post-translationally modified peptides (RiPPs) represent a valuable class of natural products, often featuring macrocyclization, which enhances stability and rigidity to achieve specific conformations, frequently underlying antibiotic activity. ChlB is a metalloenzyme with two catalytic domains─a radical S-adenosyl-l-methionine (SAM) domain and an α-ketoglutarate-dependent oxygenase─that work in tandem to sequentially form three cyclophanes and introduce three hydroxyl groups into its substrate peptide, ChlA. Here, we present the crystal structure of the radical SAM domain of ChlB in complex with ChlA, revealing the mechanism underlying cyclophane formation. These structures also elucidate how the leader sequence of ChlA interacts with ChlB. By combining structural, in vitro, and in vivo approaches, we determined the precise sequence of the three cyclophane formations, interspersed with hydroxylation events. Our findings demonstrate a back-and-forth movement of the core peptide between the radical SAM domain and the oxygenase domain, which drives the stepwise modification process, leading to the fully modified peptide.
- 12 May 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (20) , 16850-16863
Peptide Recognition and Mechanism of the Radical S-Adenosyl-l-methionine Multiple Cyclophane Synthase ChlB
Ribosomally synthesized and post-translationally modified peptides (RiPPs) represent a valuable class of natural products, often featuring macrocyclization, which enhances stability and rigidity to achieve specific conformations, frequently underlying antibiotic activity. ChlB is a metalloenzyme with two catalytic domains─a radical S-adenosyl-l-methionine (SAM) domain and an α-ketoglutarate-dependent oxygenase─that work in tandem to sequentially form three cyclophanes and introduce three hydroxyl groups into its substrate peptide, ChlA. Here, we present the crystal structure of the radical SAM domain of ChlB in complex with ChlA, revealing the mechanism underlying cyclophane formation. These structures also elucidate how the leader sequence of ChlA interacts with ChlB. By combining structural, in vitro, and in vivo approaches, we determined the precise sequence of the three cyclophane formations, interspersed with hydroxylation events. Our findings demonstrate a back-and-forth movement of the core peptide between the radical SAM domain and the oxygenase domain, which drives the stepwise modification process, leading to the fully modified peptide.
- Open Access
- 17 March 2025
- Published by Springer Nature in Nature Chemistry
- p. 1
Author Correction: Fused radical SAM and αKG-HExxH domain proteins contain a distinct structural fold and catalyse cyclophane formation and β-hydroxylation
- 17 March 2025
- Published by Springer Nature in Nature Chemistry
- p. 1
Open AccessAuthor Correction: Fused radical SAM and αKG-HExxH domain proteins contain a distinct structural fold and catalyse cyclophane formation and β-hydroxylation
- Open Access
Antibiotics that Kill Gram-negative Bacteria by Restructuring the Outer Membrane Protein BamA
Summary: The essential outer membrane protein insertase BamA has recently emerged as a valid target for killing Gram-negative bacteria. Bamabactins, competitive inhibitors targeting the lateral gate of BamA, disrupt the substrate folding process, compromise the outer membrane integrity, and lead to bacterial cell death. Despite their promise, the full pharmacological potential of bamabactins remains underexploited. We applied phylogenetic genome mining and synthetic biology to identify xenorceptides which selectively kill Enterobacteriaceae . Mode of action studies show that xenorceptide A2 integrates itself into BamA as an additional β-strand between β1 and β16 at the lateral gate, inducing a conformation of BamA that has not been observed before. Biological evaluation of xenorceptide A2 shows promising activity in vitro and in vivo , and limited resistance which differentiates it from other bamabactin antibiotics. Our data show that the chemical diversity of bamabactins is far greater than previously recognized and thus an attractive source for antibiotic discovery.
Open AccessAntibiotics that Kill Gram-negative Bacteria by Restructuring the Outer Membrane Protein BamA
Summary: The essential outer membrane protein insertase BamA has recently emerged as a valid target for killing Gram-negative bacteria. Bamabactins, competitive inhibitors targeting the lateral gate of BamA, disrupt the substrate folding process, compromise the outer membrane integrity, and lead to bacterial cell death. Despite their promise, the full pharmacological potential of bamabactins remains underexploited. We applied phylogenetic genome mining and synthetic biology to identify xenorceptides which selectively kill Enterobacteriaceae . Mode of action studies show that xenorceptide A2 integrates itself into BamA as an additional β-strand between β1 and β16 at the lateral gate, inducing a conformation of BamA that has not been observed before. Biological evaluation of xenorceptide A2 shows promising activity in vitro and in vivo , and limited resistance which differentiates it from other bamabactin antibiotics. Our data show that the chemical diversity of bamabactins is far greater than previously recognized and thus an attractive source for antibiotic discovery.
- Open Access
- 23 October 2024
- Published by Royal Society of Chemistry (RSC) in RSC Chemical Biology
- Vol. 5 (12) , 1195-1200
Sequence-function space of radical SAM cyclophane synthases reveal conserved active site residues that influence substrate specificity
The uncharacterized rSAM enzyme HtkB from Pandoraea sp. catalyzes a HisC2-to-LysCβ crosslink. ColabFold and mutagenesis was used to reveal residues D214 in HtkB and H204 in HaaB are important for substrate specificity.
- 23 October 2024
- Published by Royal Society of Chemistry (RSC) in RSC Chemical Biology
- Vol. 5 (12) , 1195-1200
Open AccessSequence-function space of radical SAM cyclophane synthases reveal conserved active site residues that influence substrate specificity
The uncharacterized rSAM enzyme HtkB from Pandoraea sp. catalyzes a HisC2-to-LysCβ crosslink. ColabFold and mutagenesis was used to reveal residues D214 in HtkB and H204 in HaaB are important for substrate specificity.
- 18 September 2024
- Published by Springer Nature in Nature Chemistry
- Vol. 16 (11) , 1882-1893
Fused radical SAM and αKG-HExxH domain proteins contain a distinct structural fold and catalyse cyclophane formation and β-hydroxylation
Two of nature’s recurring binding motifs in metalloproteins are the CxxxCxxC motif in radical SAM enzymes and the 2-His-1-carboxylate motif found both in zincins and α-ketoglutarate and non-haem iron enzymes. Here we show the confluence of these two domains in a single post-translational modifying enzyme containing an N-terminal radical S-adenosylmethionine domain fused to a C-terminal 2-His-1-carboxylate (HExxH) domain. The radical SAM domain catalyses three-residue cyclophane formation and is the signature modification of triceptides, a class of ribosomally synthesized and post-translationally modified peptides. The HExxH domain is a defining feature of zinc metalloproteases. Yet the HExxH motif-containing domain studied here catalyses β-hydroxylation and is an α-ketoglutarate non-haem iron enzyme. We determined the crystal structure for this HExxH protein at 2.8 Å, unveiling a distinct structural fold, thus expanding the family of α-ketoglutarate non-haem iron enzymes with a class that we propose to name αKG-HExxH. αKG-HExxH proteins represent a unique family of ribosomally synthesized and post-translationally modified peptide modifying enzymes that can furnish opportunities for genome mining, synthetic biology and enzymology.
- 18 September 2024
- Published by Springer Nature in Nature Chemistry
- Vol. 16 (11) , 1882-1893
Fused radical SAM and αKG-HExxH domain proteins contain a distinct structural fold and catalyse cyclophane formation and β-hydroxylation
Two of nature’s recurring binding motifs in metalloproteins are the CxxxCxxC motif in radical SAM enzymes and the 2-His-1-carboxylate motif found both in zincins and α-ketoglutarate and non-haem iron enzymes. Here we show the confluence of these two domains in a single post-translational modifying enzyme containing an N-terminal radical S-adenosylmethionine domain fused to a C-terminal 2-His-1-carboxylate (HExxH) domain. The radical SAM domain catalyses three-residue cyclophane formation and is the signature modification of triceptides, a class of ribosomally synthesized and post-translationally modified peptides. The HExxH domain is a defining feature of zinc metalloproteases. Yet the HExxH motif-containing domain studied here catalyses β-hydroxylation and is an α-ketoglutarate non-haem iron enzyme. We determined the crystal structure for this HExxH protein at 2.8 Å, unveiling a distinct structural fold, thus expanding the family of α-ketoglutarate non-haem iron enzymes with a class that we propose to name αKG-HExxH. αKG-HExxH proteins represent a unique family of ribosomally synthesized and post-translationally modified peptide modifying enzymes that can furnish opportunities for genome mining, synthetic biology and enzymology.
- 24 June 2024
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 81, 102483
Accessing and exploring the unusual chemistry by radical SAM-RiPP enzymes
- 24 June 2024
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 81, 102483
Accessing and exploring the unusual chemistry by radical SAM-RiPP enzymes
- 14 May 2024
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 19 (6) , 1229-1236
The Triceptide Maturase OscB Catalyzes Uniform Cyclophane Topology and Accepts Diverse Gly-Rich Precursor Peptides
Triceptides are a class of ribosomally synthesized and post-translationally modified peptides defined by an aromatic C(sp2) to Cβ(sp3) bond. The Gly-rich repeat family of triceptide maturases (TIGR04261) are paired with precursor peptides (TIGR04260) containing a Gly-rich core peptide. These maturases are prevalent in cyanobacteria and catalyze cyclophane formation on multiple Ω1-X2-X3 motifs (Ω1 = Trp and Phe) of the Gly-rich precursor peptide. The topology of the individual rings has not been completely elucidated, and the promiscuity of these enzymes is not known. In this study, we characterized all the cyclophane rings formed by the triceptide maturase OscB and show the ring topology is uniform with respect to the substitution at Trp-C7 and the atropisomerism (planar chirality). Additionally, the enzyme OscB demonstrated substrate promiscuity on Gly-rich precursors and can accommodate a diverse array of engineered sequences. These findings highlight the versatility and implications for using OscB as a biocatalyst for producing polycyclophane-containing peptides for biotechnological applications.
- 14 May 2024
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 19 (6) , 1229-1236
The Triceptide Maturase OscB Catalyzes Uniform Cyclophane Topology and Accepts Diverse Gly-Rich Precursor Peptides
Triceptides are a class of ribosomally synthesized and post-translationally modified peptides defined by an aromatic C(sp2) to Cβ(sp3) bond. The Gly-rich repeat family of triceptide maturases (TIGR04261) are paired with precursor peptides (TIGR04260) containing a Gly-rich core peptide. These maturases are prevalent in cyanobacteria and catalyze cyclophane formation on multiple Ω1-X2-X3 motifs (Ω1 = Trp and Phe) of the Gly-rich precursor peptide. The topology of the individual rings has not been completely elucidated, and the promiscuity of these enzymes is not known. In this study, we characterized all the cyclophane rings formed by the triceptide maturase OscB and show the ring topology is uniform with respect to the substitution at Trp-C7 and the atropisomerism (planar chirality). Additionally, the enzyme OscB demonstrated substrate promiscuity on Gly-rich precursors and can accommodate a diverse array of engineered sequences. These findings highlight the versatility and implications for using OscB as a biocatalyst for producing polycyclophane-containing peptides for biotechnological applications.